IZ Express

Issue 1804: March 19, 2025

Top Stories
 
Immunize​.org Website and Clinical Resources 
 
Vaccine Information Statements
 
Featured Resources
    
Upcoming Events

Top Stories

“Human Cases of Highly Pathogenic Avian Influenza A(H5N1)—California, September–December 2024” published in MMWR

CDC published Human Cases of Highly Pathogenic Avian Influenza A(H5N1)—California, September–December 2024 on March 13 in MMWR. A portion of the summary appears below. 

Persons with occupational exposure to highly pathogenic avian influenza (HPAI) A(H5N1) virus–infected dairy cattle are at increased risk for infection. . . .

During September 30–December 24, 2024, a total of 38 persons received a positive test result for HPAI A(H5N1) viruses in California; 37 were dairy farm workers with occupational exposure to sick cows. One, a person aged <18 years with an undetermined exposure, was the first pediatric patient detected with influenza A(H5) infection in the United States. . . .

Public health agencies should investigate influenza-like illness or conjunctivitis in workers with occupational exposure to animals infected with HPAI A(H5N1) virus. Thorough investigations of all human HPAI A(H5N1) virus infections are necessary to identify potential exposure sources, including monitoring the virus for concerning genetic changes that indicate the potential for person-to-person transmission.


Access the MMWR article in HTML or PDF.

Related Link

  • CDC: MMWR main page providing access to the MMWR family of publications

Unity Consortium posts toolkit to help you prepare for Adolescent Immunization Action Week, April 7–11

Celebrated April 7–11 this year, Adolescent Immunization Action Week (#AIAW25) urges parents, healthcare providers, and adolescents to keep teenagers up to date. Visit Unity’s AIAW campaign page for social media-ready materials to draw attention to improving coverage. Use the hashtag #AIAW25 to spread the word.



Unity’s password-protected toolkit includes graphics and a short article about the observance for emails, newsletters, or blogs. To access this, sign up at the bottom of the AIAW25 web page.


Immunize​.org updates patient handout: "Immunizations for Babies: A Guide for Parents"

Immunize​.org corrected an error on the Immunizations for Babies: A Guide for Parents. The small print indicating the timeframe for the final Hib vaccine dose listed on the 12 months and older row displayed the wrong age range for administration. It was corrected to display the correct range of 12–15 months.

Related Links


Influenza activity has peaked, but remains widespread; deaths of 134 U.S. children reported so far this season

For week 10, ending March 8, CDC’s Weekly Influenza Surveillance Report, FluView, showed influenza-like illness activity at high to very high levels in 25 of 39 reporting jurisdictions. This season is a high-severity season for people of all ages. During week 10, 4.3% of outpatient visits were for influenza-like illness, well above the epidemic threshold of 3.0% for the fifteenth consecutive week. Twenty pediatric deaths associated with seasonal influenza virus infection were reported during week 10, bringing the 2024–25 season total to 134 childhood deaths due to influenza.



RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for weekly reports of hospitalizations due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV. COVID-19 vaccination is recommended for everyone age 6 months and older; RSV vaccination at this point in the season is recommended for certain high-risk adults age 60 through 74 and all adults age 75 years and older. RSV immunization of infants and certain high-risk toddlers with nirsevimab (Beyfortus, Sanofi) is recommended until the end of March.

Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard shows that, as of March 1, 37.9% of pregnant patients had received influenza vaccination, although coverage rates differ widely by racial and ethnic group. Vaccination coverage was highest among non-Hispanic Asian pregnant patients (53.3%) and lowest among non-Hispanic Black pregnant patients (26.2%). Vaccination during pregnancy is important to protect both mother and infant from the consequences of influenza infection.

CDC recommends everyone age 6 months and older get annual influenza vaccination. Given the high levels of circulating influenza across the country, vaccination remains important for all eligible, unvaccinated people.

Identify pharmacies in your area that may offer influenza and COVID-19 vaccines by entering a zip code in the VaccineFinder on Vaccines.gov or Vacunas.gov.

Related Links


NFID shares multimedia measles resources

NFID.org provides resources in its NFID Resource Library to help increase awareness and prevent further spread of measles. Measles resources from NFID include:



Share widely to help combat misinformation and promote measles vaccination.


Immunize​.org's Influenza Vaccination Honor Roll for healthcare worker vaccination requirements welcomes a new facility 

Immunize​.org's Influenza Vaccination Honor Roll recognizes facilities that take a stand for patient safety by implementing policies requiring healthcare personnel influenza vaccination. Immunize​.org welcomes Harris Health, Bellaire, TX, to our honor roll.



Eligibility
  • Eligible organizations: hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
  • Requirements:
    • Your policy must require influenza vaccination for all staff
    • The application must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire shift)
Related Links

“Is RSV Vaccine an Annual Vaccination Like Influenza?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube. 

This week, our featured episode from the Ask the Experts Video Series is titled Is RSV Vaccine an Annual Vaccination Like Influenza? The video highlights that RSV vaccines, which are recommended during pregnancy, for all adults 75 and older, and for high risk adults age 60 through 74, are currently approved and recommended only for a single dose. Revaccination is not recommended at this time.

The 1-minute video is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions.

Like, follow, and share Immunize​.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.


Journalists interview Immunize​.org experts

Journalists seek out Immunize​.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a recent citation.


Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.


Immunize​.org Website and Clinical Resources

Spotlight on the website: institutional honor rolls for vaccination excellence

This week’s Spotlight is on our three honor rolls. Immunize​.org recognizes healthcare organizations and colleges/universities that excel in vaccination policy and practice.   

You can locate the honor rolls under the “About” menu tab by selecting the “Recognizing Excellence” menu item. Links are provided to each honor roll with an option to view the current honorees. 



The Influenza Vaccination Honor Roll recognizes healthcare organizations that require influenza vaccination for employees to protect their patients. Honorees include 1,245 healthcare systems, hospitals, medical practices, pharmacies, and others.

The Hepatitis B Birth Dose Honor Roll recognizes U.S. birthing institutions that achieve a hepatitis B vaccine birth dose coverage rate of 90% or greater. Honorees must also adopt birth dose policies, procedures, and protocols. Currently, there are 587 honorees.   

The MenB Vaccination Honor Roll recognizes institutions of higher education that adopt policies requiring or recommending MenB vaccination to protect their students and help prevent outbreaks. There are 271 honorees currently listed.  

Each honor roll landing page lists the requirements for your institution to be included and displays an online application. Relevant links to government vaccination mandates, position statements from leading medical organizations, journal articles, editorials, websites, toolkits, and personal stories from those affected by these vaccine-preventable diseases are provided.  

You can look for your institution among current honor roll honorees on a single page. Filter honorees by honor roll type, facility type, and by U.S. state, territory, or military base abroad. 


Recap: Immunize​.org reviews, updates “Ask the Experts: Administering Vaccines,” web section

Immunize​.org reviewed and updated the contents of its Ask the Experts: Administering Vaccines web page. Links to CDC resources were updated and content concerning new vaccines added, as needed.


Vaccine Information Statements

Recap: CDC posts revisions to 17 VISs in compliance with Presidential Executive Order; check that your VIS collection is current

CDC recently posted revisions of 17 VISs, dated January 31, 2025, on its Current VISs web page. The revisions comply with the January 20, 2025, Presidential Executive Order: Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. Each of these VISs was changed so that the words "women," "woman," and "she" replace the words “persons, “person,” and “they” when referring to pregnancy or breastfeeding. Users will also note that the VISs have a new CDC logo.

Web links to the revised VISs are shown below.

Cholera                  Influenza, live                            Polio
COVID-19 Influenza, recombinant RSV
Dengue MMR Smallpox/Monkeypox
Ebola MMRV Tdap
Hepatitis A Meningococcal AWCY Varicella
Hepatitis B Meningococcal B  

Each revised VIS is posted at Immunize.org to help you provide current VISs to each of your patients before vaccinating them. Federal law allows up to 6 months for a new VIS to be used. For more on this, see You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!

Dates of Current Vaccine Information Statements (VISs) is another useful document to help you ensure that you distribute the most recent VISs.

You can use Immunize.org’s clinical resources (created in 2024) with our own QR code links to VISs. These codes will always link you to the current CDC VIS:

Translations of the newly revised VISs are not available. When a recipient needs a translation, provide the out-of-date translation along with the current federal VIS in English.


Featured Resources

While supplies last, order laminated 2025 U.S. immunization schedule booklets from Immunize​.org

Laminated booklets of the 2025 U.S. child and adolescent immunization schedule and the 2025 U.S. adult immunization schedule are available now in the Immunize.org shop.

The schedules are available online as PDFs from CDC at no cost. Immunize​.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given. Features include:

  • Durability: Their tough coating can be wiped down, and they can stand up to a year's worth of use.
  • Format: Each schedule is produced in an 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes. The adult schedule is 16 pages and the child and adolescent schedule is 20 pages.
  • Easy access to CDC updates: The CDC online schedule includes an addendum page that will display ACIP’s new recommendations as CDC adopts them during 2025. Each Immunize​.org laminated schedule addendum page includes QR codes you can scan to view or print the online addendum page as it is revised.
  • Bonus content: Both schedules include a bonus page with Immunize​.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients.

 

Pricing:

Child and Adolescent Booklets            Adult Booklets
1 copy: $10.50   1 copy: $10.00
2–4 copies: $10.00 each   2–4 copies: $9.50 each
5–19 copies: $9.00 each   5–19 copies: $8.50 each
20–99 copies: $8.00 each   20–99 copies: $7.50 each
100–499 copies: $6.50 each   100–499 copies: $6.00 each
500–999 copies: $5.50 each   500–999 copies: $5.00 each
1,000–1,999 copies: $4.50 each   1,000–1,999 copies: $4.00 each
2,000+ copies: $3.75 each   2,000+ copies: $3.25 each
     
Visit the Shop Immunize​.org: Laminated Schedules web page to view images and order today!

For additional information, call 651-647-9009 or email admininfo@immunize.org.

Related Links
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults

Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. This influenza season has been a tough one and it is not over yet. To help you maximize patient protection, Immunize​.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense website.



This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:

Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a patient will get vaccinated.

Check out the updated 65+ Flu Defense website to assist your ongoing efforts in protecting this vulnerable population.


Need to teach vaccine administration? Use Immunize​.org’s Vaccinating Adults: A Step-by-Step Guide—free to download

Download Immunize​.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide).

 

This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.

The Guide is available to download/print either by chapter or in its entirety free of charge. The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.

The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!

Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.

Related Links


Upcoming Events

Tomorrow! Virtual: NFID and AMGA host webinar “Improving U.S. Adult Vaccination Rates” featuring Immunize​.org’s L.J Tan, PhD, on March 20 at 2:00 p.m. (ET); CE credit available.   

NFID and the American Medical Group Association (AMGA) will host a webinar titled Improving U.S. Adult Vaccination Rates at 2:00 p.m. on March 20. The panel includes NFID Medical Director Robert Hopkins; Jean-Venable (Kelly) Goode, PharmD, professor at Virginia Commonwealth University; and Immunize.org’s Litjen Tan, MS, PhD. Speakers will discuss current adult vaccine recommendations, vaccination challenges and barriers, and strategies to improve vaccination rates.

CME and CNE credit are available. There is no fee to participate, but preregistration is required.

Register for the webinar



NFID hosts monthly webinars to increase awareness of the importance of infectious disease prevention and treatment. CME, CNE, and CPE credits are available for select recordings. View all archived NFID webinars.


Virtual: North Dakota State University hosts webinar titled “When Measles Strikes: Engaging Community Partners in Outbreak Response” on March 27 at 1:00 p.m. (ET); CE credit available

North Dakota State University's Center for Immunization Research and Education (CIRE) will host a webinar titled When Measles Strikes: Engaging Community Partners in Outbreak Response, 1:00–2:00 p.m. (ET) on March 27. During this webinar, Lynn Bahta, MPH, BSN, and Molly Howell, MPH, will describe current measles epidemiology, its effect on communities, how to collaborate with affected communities to enhance outbreak response, and the role of trust and communication in promoting vaccination and containment.

Register for the webinar.

CIRE offers free access to recordings of its monthly webinars on its website. Participants who watch the full recording and complete the pre- and post-training quizzes may earn free CE credit for each webinar. Learn more about CE opportunities.


In-person and virtual: Clinical Care Options hosts event titled “Removing Roadblocks: Practical Approaches to Increase Adult RSV Vaccine Uptake," on April 1 at 1:15 p.m. (ET); CME credit available

Clinical Care Options will host an event titled Removing Roadblocks: Practical Approaches to Increase Adult RSV Vaccine Uptake, in person and virtually from 1:15–2:15 p.m. (ET) on April 1. The in-person event is open to registered participants at the American College of Physicians (ACP) annual meeting in New Orleans. Virtual attendance is open to anyone. Participants will learn to identify RSV vaccination candidates, explore approaches to patient counseling, and examine barriers to RSV vaccination. Presenters include Immunize.org’s Carolyn Bridges, MD, FACP, and Laura P. Hurley, MD, MPH, associate professor of medicine, University of Colorado Anschutz Medical Campus.

There is no fee to attend virtually. CME and CE credit are available.

Register for the event.


Virtual: Dr. Paul Offit discusses “Is a Bird Flu Pandemic Likely?” on webinar, April 2 at 12:00 p.m. (ET); CE credit available

The Vaccine Education Center (VEC) at Children's Hospital of Philadelphia and its partners will present a 1-hour webinar titled Is a Bird Flu Pandemic Likely? at 12:00 p.m. (ET) on April 2. Part of its Current Issues in Vaccines series, the webinar will feature Paul Offit, MD, director of the VEC.

Free continuing education credits (CME, CEU, and CPE) will be available for live and archived events.

Register for the webinar.


Virtual: Register for the next Immunize​.org Website Office Hours on April 9 at 4:00 p.m. (ET) or April 10 at 12:00 p.m. (ET). Ask your website questions and learn about our publication archives and vaccine timeline. Previously recorded sessions available online.

To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, April 9 at 4:00 p.m. (ET) or Thursday, April 10 at 12:00 p.m. (ET). The same content will be covered in both sessions. 
 
We will open each 45-minute session with a short, live demonstration on navigating the following site content: publication archives, vaccine timeline, and about us. You can submit questions when you register or live on Zoom during the session.

Register today for Immunize​.org Website Office Hours (content is the same for both): 

The archive of previous Website Office Hours content is posted at Immunize​.org’s Webinars & Videos page. Website sections covered in the archived webinars include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Images, Webinars, Videos, & Social Media; Official Guidance; Travel Vaccines, Vaccine Confidence & Addressing Concerns; and Vaccines A-Z.

Mark your calendar for future Immunize​.org Website Office Hours. 


For more upcoming events, visit our Calendar of Events.

About IZ Express

IZ Express is supported in part by Grant No. NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .